1. Home
  2. PTHL vs PFX Comparison

PTHL vs PFX Comparison

Compare PTHL & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • PFX
  • Stock Information
  • Founded
  • PTHL 1998
  • PFX 2010
  • Country
  • PTHL China
  • PFX United States
  • Employees
  • PTHL N/A
  • PFX N/A
  • Industry
  • PTHL
  • PFX Finance: Consumer Services
  • Sector
  • PTHL
  • PFX Finance
  • Exchange
  • PTHL Nasdaq
  • PFX Nasdaq
  • Market Cap
  • PTHL 85.4M
  • PFX 98.5M
  • IPO Year
  • PTHL 2024
  • PFX N/A
  • Fundamental
  • Price
  • PTHL $0.63
  • PFX $49.25
  • Analyst Decision
  • PTHL
  • PFX
  • Analyst Count
  • PTHL 0
  • PFX 0
  • Target Price
  • PTHL N/A
  • PFX N/A
  • AVG Volume (30 Days)
  • PTHL 3.5M
  • PFX 596.0
  • Earning Date
  • PTHL 01-01-0001
  • PFX 08-06-2025
  • Dividend Yield
  • PTHL N/A
  • PFX 2.90%
  • EPS Growth
  • PTHL N/A
  • PFX N/A
  • EPS
  • PTHL N/A
  • PFX 3.06
  • Revenue
  • PTHL $448,196.00
  • PFX $23,958,590.00
  • Revenue This Year
  • PTHL N/A
  • PFX $10.51
  • Revenue Next Year
  • PTHL N/A
  • PFX N/A
  • P/E Ratio
  • PTHL N/A
  • PFX $16.10
  • Revenue Growth
  • PTHL N/A
  • PFX 7.47
  • 52 Week Low
  • PTHL $0.60
  • PFX $44.56
  • 52 Week High
  • PTHL $32.00
  • PFX $57.40
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • PFX 46.04
  • Support Level
  • PTHL N/A
  • PFX $49.25
  • Resistance Level
  • PTHL N/A
  • PFX $50.35
  • Average True Range (ATR)
  • PTHL 0.00
  • PFX 0.20
  • MACD
  • PTHL 0.00
  • PFX -0.05
  • Stochastic Oscillator
  • PTHL 0.00
  • PFX 26.47

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: